Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
articles

Latest articles        [more info]
Articles in Volume 2
Editorial    
Are there fundamental deficiencies in the megatrial methodology?
Desmond Julian, Curt Furberg
Current Controlled Trials in Cardiovascular Medicine 2001, 2:1 (9 February 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Commentary    
Fundamental deficiencies in the megatrial methodology
Bruce G Charlton
Current Controlled Trials in Cardiovascular Medicine 2001, 2:2-7 (30 January 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Commentary    
Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"
Sergio Fazio, MacRae F Linton
Current Controlled Trials in Cardiovascular Medicine 2001, 2:8-11 (30 January 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Commentary    
Debate: "How low should LDL cholesterol be lowered for optimum prevention of vascular disease?" Viewpoint: "Below 100 mg/dl"
W Virgil Brown MD
Current Controlled Trials in Cardiovascular Medicine 2001, 2:12-15 (9 February 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Commentary    
The Proliferation REduction with Vascular ENergy Trial (PREVENT)
Albert E Raizner, Grzegorz L Kaluza
Current Controlled Trials in Cardiovascular Medicine 2001, 2:16-19 (1 February 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Commentary    
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
Eric J Eichhorn, Michael R Bristow
Current Controlled Trials in Cardiovascular Medicine 2001, 2:20-23 (2 February 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Review    
The current status of primary prevention in coronary heart disease
Cornel Pater
Current Controlled Trials in Cardiovascular Medicine 2001, 2:24-37 (30 January 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Review    
Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials
Steven Warach
Current Controlled Trials in Cardiovascular Medicine 2001, 2:38-44 (30 January 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Review    
New immunosuppressive drugs in heart transplantation
Maria Rosa Costanzo
Current Controlled Trials in Cardiovascular Medicine 2001, 2:45-53 (8 February 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Research    
Experience collecting interim data on mortality: an example from the RALES study
Janet Wittes, Jolie Palensky, Debra Asner, Desmond Julian, Jean-Pierre Boissel, Curt D Furberg, Henri Kulbertus, Stuart Pocock, Barbara Roniker
Current Controlled Trials in Cardiovascular Medicine 2001, 2:59-62 (7 February 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Commentary    
Debate: does it matter how you lower blood pressure?
Gordon T McInnes
Current Controlled Trials in Cardiovascular Medicine 2001, 2:63-66 (1 March 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Commentary    
Ablation of atrial fibrillation: a procedure come of age?
J Marcus Wharton
Current Controlled Trials in Cardiovascular Medicine 2001, 2:67-70 (5 April 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Commentary    
New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products
William M Vollmer, Frank M Sacks, Laura P Svetkey
Current Controlled Trials in Cardiovascular Medicine 2001, 2:71-74 (11 April 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Review    
Implications of troponin testing in clinical medicine
Britta U Goldmann, Robert H Christenson, Christian W Hamm, Thomas Meinertz, E Magnus Ohman
Current Controlled Trials in Cardiovascular Medicine 2001, 2:75-84 (11 April 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Meeting report    
Selected highlights from the 50th Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001
Joanna Lyford
Current Controlled Trials in Cardiovascular Medicine 2001, 2:85-89 (11 April 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Research    
No effects on myocardial ischaemia in patients with stable ischaemic heart disease after treatment with ramipril for 6 months
Ronnie Willenheimer, Steen Juul-Möller, Lennart Forslund, Leif Erhardt
Current Controlled Trials in Cardiovascular Medicine 2001, 2:99-105 (4 April 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Commentary    
The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions
Curt D Furberg
Current Controlled Trials in Cardiovascular Medicine 2001, 2:107-108 (31 May 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Commentary    
Bridging case-control studies and randomized trials
Frits R Rosendaal
Current Controlled Trials in Cardiovascular Medicine 2001, 2:109-110 (31 May 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Commentary    
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?
David Waters, Gregory G Schwartz, Anders G Olsson
Current Controlled Trials in Cardiovascular Medicine 2001, 2:111-114 (31 May 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Commentary    
Data quality assurance and quality control measures in large multicenter stroke trials: the African-American Antiplatelet Stroke Prevention Study experience
DeJuran Richardson, Shande Chen
Current Controlled Trials in Cardiovascular Medicine 2001, 2:115-117 (25 May 2001)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

next page   
register
Trials
BioMed Central
Current Controlled
Trials
PubMed
PubMed Central




© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.